Damián Ochoa Guette
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Damián Ochoa Guette has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Breallan De Jesús Romero Pajaro
Faculty of Health Sciences, Department of Internal Medicine, Universidad Libre Barranquilla Campus, Barranquilla 08000, Colombia
3 shared publications - Amilkar José Almanza Hurtado
Faculty of Health Sciences, Department of Critical Care, Universidad de Cartagena Campus, Av. El Bosque, Transversal 54 No. 30-453, Santillana, Cartagena de Indias 130015, Colombia
2 shared publications Eduardo Tuta-Quintero
2 shared publications- Jennifer Patricia Vargas Gomez
Faculty of Health Sciences, Department of Internal Medicine, Universidad Libre Barranquilla Campus, Barranquilla 08000, Colombia
2 shared publications - Rafael Tous Bertel
Critical Care Medicine Resident, Universidad del Sinú, Monteria, Colombia, Colombia
2 shared publications Angelica Vanesa Mora Barrero
1 shared publication
Latest Publications
- Open Access
Secondary Hemophagocytic Lymphohistiocytosis Mimicking Sepsis in Adults: A Case Series
Background and Clinical Significance: Secondary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that can closely resemble sepsis in adults, potentially delaying recognition and treatment. Because infection may trigger or coexist with HLH, persistent or disproportionate inflammation despite appropriate antimicrobial therapy should prompt reassessment for concomitant HLH and investigation of the underlying trigger; Case Presentation: We describe three adults initially managed for presumed sepsis or severe infection at a referral hospital in Colombia. All developed persistent fever, cytopenias, organomegaly, and marked hyperferritinemia. HScore values were 222, 246, and 248, respectively; the score in Case 3 was calculated retrospectively from available pretreatment data. Bone marrow hemophagocytosis was demonstrated in Cases 1 and 2 but not in Case 3. The underlying triggers were acute myeloid leukemia, disseminated histoplasmosis in the setting of advanced HIV infection, and visceral leishmaniasis. The malignancy-associated case had an unfavorable outcome. Both infection-associated cases improved after pathogen-directed therapy combined with corticosteroids to control hyperinflammation, without escalation to an etoposide-based regimen; Conclusions: Sepsis and secondary HLH should not be regarded as mutually exclusive diagnoses. Persistent or disproportionate inflammation accompanied by progressive multilineage cytopenias, splenomegaly, markedly elevated or rising ferritin levels, hypertriglyceridemia, and/or decreasing fibrinogen should prompt early HScore calculation, assessment of HLH-2004 criteria, and concurrent investigation for an underlying trigger. Recognition of the clinical pattern and individualized treatment of both the trigger and hyperinflammatory state may facilitate timely management.
Open AccessSecondary Hemophagocytic Lymphohistiocytosis Mimicking Sepsis in Adults: A Case Series
Background and Clinical Significance: Secondary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that can closely resemble sepsis in adults, potentially delaying recognition and treatment. Because infection may trigger or coexist with HLH, persistent or disproportionate inflammation despite appropriate antimicrobial therapy should prompt reassessment for concomitant HLH and investigation of the underlying trigger; Case Presentation: We describe three adults initially managed for presumed sepsis or severe infection at a referral hospital in Colombia. All developed persistent fever, cytopenias, organomegaly, and marked hyperferritinemia. HScore values were 222, 246, and 248, respectively; the score in Case 3 was calculated retrospectively from available pretreatment data. Bone marrow hemophagocytosis was demonstrated in Cases 1 and 2 but not in Case 3. The underlying triggers were acute myeloid leukemia, disseminated histoplasmosis in the setting of advanced HIV infection, and visceral leishmaniasis. The malignancy-associated case had an unfavorable outcome. Both infection-associated cases improved after pathogen-directed therapy combined with corticosteroids to control hyperinflammation, without escalation to an etoposide-based regimen; Conclusions: Sepsis and secondary HLH should not be regarded as mutually exclusive diagnoses. Persistent or disproportionate inflammation accompanied by progressive multilineage cytopenias, splenomegaly, markedly elevated or rising ferritin levels, hypertriglyceridemia, and/or decreasing fibrinogen should prompt early HScore calculation, assessment of HLH-2004 criteria, and concurrent investigation for an underlying trigger. Recognition of the clinical pattern and individualized treatment of both the trigger and hyperinflammatory state may facilitate timely management.
- Open Access
- 3 July 2026
- Published by MDPI AG in Preprints.org
Secondary Hemophagocytic Lymphohistiocytosis Mimicking Sepsis in Adults: A Case Series
Background: Hemophagocytic lymphohistiocytosis is a life-threatening hyperinflammatory syndrome that can mimic sepsis in adults, delaying diagnosis and treatment. Methods: We reviewed three adult patients admitted to a high-complexity referral hospital in Colombia, all initially managed as sepsis, analyzing clinical findings, laboratory results, bone marrow studies, diagnostic approach, and outcomes. Results: All patients had persistent fever, cytopenias, organomegaly, hyperferritinemia, and hypertriglyceridemia, with ongoing inflammation despite appropriate antimicrobial therapy. Bone marrow examination showed hemophagocytosis in all cases. One case was associated with acute myeloid leukemia and had a poor outcome, while two infection-related cases, triggered by disseminated histoplasmosis and visceral leishmaniasis, improved with targeted therapy and supportive care. Conclusions: Persistent inflammation, cytopenias, and markedly elevated ferritin despite standard sepsis treatment should prompt early consideration of hemophagocytic lymphohistiocytosis and investigation of the underlying trigger.
- 3 July 2026
- Published by MDPI AG in Preprints.org
Open AccessSecondary Hemophagocytic Lymphohistiocytosis Mimicking Sepsis in Adults: A Case Series
Background: Hemophagocytic lymphohistiocytosis is a life-threatening hyperinflammatory syndrome that can mimic sepsis in adults, delaying diagnosis and treatment. Methods: We reviewed three adult patients admitted to a high-complexity referral hospital in Colombia, all initially managed as sepsis, analyzing clinical findings, laboratory results, bone marrow studies, diagnostic approach, and outcomes. Results: All patients had persistent fever, cytopenias, organomegaly, hyperferritinemia, and hypertriglyceridemia, with ongoing inflammation despite appropriate antimicrobial therapy. Bone marrow examination showed hemophagocytosis in all cases. One case was associated with acute myeloid leukemia and had a poor outcome, while two infection-related cases, triggered by disseminated histoplasmosis and visceral leishmaniasis, improved with targeted therapy and supportive care. Conclusions: Persistent inflammation, cytopenias, and markedly elevated ferritin despite standard sepsis treatment should prompt early consideration of hemophagocytic lymphohistiocytosis and investigation of the underlying trigger.
- Open Access
- 23 April 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (9) , 1262
Biomarker-Based Diagnosis and Risk Stratification in Sepsis-Associated Acute Kidney Injury: From Molecular Mechanisms to Multimarker Panels
Sepsis-associated acute kidney injury (SA-AKI) remains a major diagnostic challenge in critically ill patients, as conventional functional criteria—serum creatinine and urine output—often detect AKI after clinically relevant pathophysiological derangement has already evolved. Increasing evidence suggests that SA-AKI reflects a heterogeneous process characterized by early cellular stress, microcirculatory dysfunction, inflammation-associated injury, and maladaptive repair preceding overt functional decline. In this context, biomarker-based approaches have been investigated to improve early risk stratification, phenotypic characterization, and prognostic assessment in septic patients. This narrative review synthesizes current evidence on established and emerging biomarkers relevant to SA-AKI, encompassing stress markers ([TIMP-2]•[IGFBP7]), tubular injury markers (e.g., NGAL, KIM-1, IL-18), functional markers (e.g., proenkephalin/penKid, cystatin C), and exploratory molecular signatures such as circulating microRNAs (miRNAs). We examine their temporal dynamics, performance estimates, and context-dependent applicability in sepsis, and discuss limitations related to heterogeneity, assay variability, and threshold standardization. Particular attention is given to multimodal and longitudinal strategies integrating biomarkers with KDIGO criteria and clinical phenotyping. Finally, we outline a stratified framework for biomarker interpretation in SA-AKI anchored to pathophysiological windows and clinical decision points. While available evidence supports the potential of selected biomarkers for short-term risk stratification and trajectory assessment, implementation requires prospective validation demonstrating incremental value beyond established models and measurable impact on patient-centered outcomes.
- 23 April 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (9) , 1262
Open AccessBiomarker-Based Diagnosis and Risk Stratification in Sepsis-Associated Acute Kidney Injury: From Molecular Mechanisms to Multimarker Panels
Sepsis-associated acute kidney injury (SA-AKI) remains a major diagnostic challenge in critically ill patients, as conventional functional criteria—serum creatinine and urine output—often detect AKI after clinically relevant pathophysiological derangement has already evolved. Increasing evidence suggests that SA-AKI reflects a heterogeneous process characterized by early cellular stress, microcirculatory dysfunction, inflammation-associated injury, and maladaptive repair preceding overt functional decline. In this context, biomarker-based approaches have been investigated to improve early risk stratification, phenotypic characterization, and prognostic assessment in septic patients. This narrative review synthesizes current evidence on established and emerging biomarkers relevant to SA-AKI, encompassing stress markers ([TIMP-2]•[IGFBP7]), tubular injury markers (e.g., NGAL, KIM-1, IL-18), functional markers (e.g., proenkephalin/penKid, cystatin C), and exploratory molecular signatures such as circulating microRNAs (miRNAs). We examine their temporal dynamics, performance estimates, and context-dependent applicability in sepsis, and discuss limitations related to heterogeneity, assay variability, and threshold standardization. Particular attention is given to multimodal and longitudinal strategies integrating biomarkers with KDIGO criteria and clinical phenotyping. Finally, we outline a stratified framework for biomarker interpretation in SA-AKI anchored to pathophysiological windows and clinical decision points. While available evidence supports the potential of selected biomarkers for short-term risk stratification and trajectory assessment, implementation requires prospective validation demonstrating incremental value beyond established models and measurable impact on patient-centered outcomes.
- 2 June 2023
- Published by Elsevier in Revista Colombiana de Reumatología
- Vol. 31 (3) , 390-398
Relación clínica entre la artritis reactiva y la infección por SARS-CoV-2: una revisión exploratoria
- 2 June 2023
- Published by Elsevier in Revista Colombiana de Reumatología
- Vol. 31 (3) , 390-398
Relación clínica entre la artritis reactiva y la infección por SARS-CoV-2: una revisión exploratoria